Mar Domingo Selected Research

Mar Domingo Research Topics

Disease

29	Heart Failure 11/2023 - 11/2007
7	Inflammation (Inflammations) 10/2022 - 04/2015
3	Fibrosis (Cirrhosis) 01/2023 - 01/2018
2	Disease Progression 01/2023 - 11/2016
2	Neoplasms (Cancer) 08/2020 - 01/2020
2	Chronic Renal Insufficiency 11/2014 - 03/2014
1	Type 2 Diabetes Mellitus (MODY) 03/2023
1	Atherosclerosis 01/2023
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2023
1	Pulmonary Hypertension 01/2022
1	Iron Deficiencies 01/2022
1	Obesity 01/2022
1	Hypertrophy 01/2021
1	COVID-19 12/2020
1	Interatrial Block 11/2018
1	ST Elevation Myocardial Infarction 01/2018
1	Heart Diseases (Heart Disease) 12/2017
1	Atrial Fibrillation 12/2017
1	Cognitive Dysfunction 11/2017
1	Anemia 09/2016
1	Systolic Heart Failure 04/2015
1	Bundle-Branch Block (Fascicular Block) 04/2015
1	Necrosis 04/2015
1	Brain Infarction 10/2013
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 10/2013
1	Hypertension (High Blood Pressure) 11/2007

Drug/Important Bio-Agent (IBA)

11	Biomarkers (Surrogate Marker)IBA 01/2023 - 04/2015
6	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2023 - 07/2012
6	pro-brain natriuretic peptide (1-76)IBA 01/2023 - 07/2012
6	Neprilysin (Neutral Endopeptidase)IBA 01/2022 - 02/2015
5	Troponin T (Troponin T1)IBA 01/2023 - 04/2015
3	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 11/2023 - 12/2017
3	Galectin 3 (LGALS3)IBA 04/2015 - 11/2014
3	CreatinineIBA 03/2014 - 11/2007
2	Peptides (Polypeptides)IBA 01/2023 - 11/2017
2	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2022 - 02/2015
2	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2022 - 01/2021
2	C-Reactive ProteinIBA 01/2020 - 04/2015
2	Hemoglobins (Hemoglobin)IBA 09/2016 - 11/2007
2	Cystatin CIBA 11/2014 - 03/2014
1	Fatty Acid-Binding ProteinsIBA 03/2023
1	TroponinIBA 01/2023
1	Procollagen Type IIBA 01/2023
1	Trinitrotoluene (TNT)IBA 01/2023
1	Collagen Type I (Type I Collagen)IBA 01/2023
1	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 01/2023
1	Proprotein Convertase 9IBA 01/2023
1	evolocumabIBA 01/2023
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023
1	procollagen type I carboxy terminal peptide (PICP)IBA 01/2023
1	LDL CholesterolIBA 01/2023
1	dapagliflozinIBA 01/2023
1	oxidized low density lipoproteinIBA 01/2023
1	Protons (Proton)IBA 10/2022
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 10/2022
1	AcetylglucosamineIBA 10/2022
1	GalactosamineIBA 10/2022
1	SymportersIBA 01/2021
1	SodiumIBA 01/2021
1	empagliflozinIBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	AntigensIBA 01/2020
1	InterleukinsIBA 01/2020
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2020
1	AnticoagulantsIBA 11/2018
1	BenzodiazepinesIBA 01/2018
1	Angiotensin Receptor AntagonistsIBA 01/2018
1	Amyloid beta-PeptidesIBA 11/2017
1	Enalapril FDA LinkGeneric 02/2015
1	IsotopesIBA 03/2014
1	AlbuminsIBA 10/2013
1	Natriuretic PeptidesIBA 07/2012

Therapy/Procedure

3	Therapeutics 01/2023 - 03/2016
1	Ambulatory Care (Outpatient Care) 12/2020
1	Palliative Care (Palliative Therapy) 10/2019
1	Patient Readmission 01/2018
1	Stents 01/2018
1	Percutaneous Coronary Intervention 01/2018
1	Drug Therapy (Chemotherapy) 03/2016